ProKidney Corp Faces Stock Volatility Amid Innovative Kidney Treatment Advances
ProKidney Corp, a biotech company, has experienced significant stock price fluctuations, but its innovative approach to kidney disease treatment remains a key differentiator in the healthcare sector.
2 minutes to read